跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CP-2
首页
药物
CP-2
CP-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Human Hookworm Vaccine
申请人: HOTEZ PETER
优先权: 2007
US
3 件公开
CASPASE-2 VARIANTS
申请人: BOEHRINGER INGELHEIM RCV GMBH
优先权: 2019
CN
EP
US
WO
5 件公开
Catalyst systems and polymer resins having improved barrier properties
申请人: DING ERRUN
优先权: 2010
US
2 件公开
Capsaicin compounds CP-X-Y with neuroprotective effect and application thereof
申请人: XINHUOZHIYAO BEIJING TECH CO LTD
优先权: 2019
CN
TAT-CP recombinant protein resisting beta Nodavirus and application
申请人: UNIV TIANJIN
优先权: 2019
CN
Method for preparing ethylene carbonate through direct reaction of carbon dioxide and ethylene glycol
申请人: ZHEJIANG DONGJIANG GREEN PETROCHEMICAL TECH INNOVATION CENTER CO LTD
优先权: 2024
CN
WCMV-CP gene with regulating effect on AMV pathogenicity and application of WCMV-CP gene
申请人: UNIV GANSU AGRICULTURAL
优先权: 2024
CN
CP-IgM antibody, preparation method and application thereof, nucleic acid molecule, carrier, cell, quality control product, kit and detection method of CP-IgM antibody
申请人: SHENZHEN YHLO BIOTECH CO LTD
优先权: 2025
CN
药物
反馈